Royal Bank Of Canada Reaffirms Outperform Rating for CVS Group (LON:CVSG)

CVS Group (LON:CVSG)‘s stock had its “outperform” rating reaffirmed by research analysts at Royal Bank Of Canada in a research report issued to clients and investors on Thursday, MarketBeat.com reports. They currently have a GBX 1,900 price target on the stock. Royal Bank Of Canada’s target price suggests a potential upside of 48.67% from the company’s previous close.

A number of other research firms also recently issued reports on CVSG. Berenberg Bank restated a “buy” rating and set a GBX 2,000 price objective on shares of CVS Group in a report on Tuesday, November 18th. Peel Hunt restated a “buy” rating and set a GBX 1,600 price target on shares of CVS Group in a research note on Tuesday, November 18th. Four investment analysts have rated the stock with a Buy rating and one has given a Hold rating to the company’s stock. According to MarketBeat, CVS Group presently has a consensus rating of “Moderate Buy” and a consensus price target of GBX 1,724.

CVS Group Stock Down 1.2%

CVSG stock traded down GBX 16 during midday trading on Thursday, reaching GBX 1,278. 273,313 shares of the company’s stock traded hands, compared to its average volume of 1,049,178. The company has a quick ratio of 0.90, a current ratio of 1.07 and a debt-to-equity ratio of 121.52. The firm’s fifty day moving average price is GBX 1,338.78 and its 200-day moving average price is GBX 1,282.95. CVS Group has a 52 week low of GBX 885 and a 52 week high of GBX 1,648. The company has a market cap of £896.59 million, a price-to-earnings ratio of 17.36, a P/E/G ratio of 1.77 and a beta of 1.31.

CVS Group (LON:CVSG) last posted its earnings results on Thursday, February 26th. The company reported GBX 40.20 earnings per share for the quarter. CVS Group had a return on equity of 5.35% and a net margin of 2.31%. As a group, sell-side analysts forecast that CVS Group will post 93.9393939 earnings per share for the current fiscal year.

Insider Activity

In other news, insider Richard Gray acquired 2,000 shares of the business’s stock in a transaction on Monday, January 5th. The shares were acquired at an average cost of £1,276.96 per share, with a total value of £2,553,920. Also, insider Joanne Shaw acquired 825 shares of the business’s stock in a transaction on Friday, December 5th. The stock was acquired at an average price of GBX 1,211 per share, for a total transaction of £9,990.75. Over the last three months, insiders have purchased 4,060 shares of company stock valued at $257,890,365. 1.42% of the stock is currently owned by insiders.

CVS Group Company Profile

CVS Group is a leading provider of veterinary services, operating in the UK and Australia, listed on the Main Market of the London Stock Exchange. CVS is focused on providing high-quality clinical services to its clients and their animals, with outstanding and dedicated clinical teams and support colleagues at the core of its strategy.

The Group operates from over 475 veterinary practices across its two territories, including specialist referral hospitals and dedicated out-of-hours sites. Alongside the core Veterinary Practices division, CVS operates Laboratories (providing diagnostic services to CVS and third-parties) and an online retail business (“Animed Direct”).

The Group employs c.8,900 personnel, including c.2,400 veterinary surgeons and c.3,300 nurses.